OverviewChartProfileKey statisticsFinancialsNewsTraderScreen

FRESEN.MED.CARE KGAA O.N./  DE0005785802  /

TradeGate
3/22/2023  8:58:41 PM Chg. -0.080 Volume Bid9:59:30 PM Ask9:59:30 PM Market Capitalization Dividend Y. P/E Ratio
37.250EUR -0.21% 14,023
Turnover: 528,396.730		 37.280Bid Size: 270 37.520Ask Size: 270 11.02 bill.EUR 3.59% 11.37

Business description

Fresenius Medical Care is the world’s leading provider of products and services for people with chronic kidney failure. Around 2.8 M patients with this disease worldwide regularly undergo dialysis treatment. Dialysis is a vital blood cleansing procedure that substitutes the function of the kidney in case of kidney failure.
 

Management board & Supervisory board

CEO
Carla Kriwet (ab 1.01.2023)
Management board
Helen Giza, Dr. Katarzyna Mazur-Hofsäß, Frank Maddux, MD, William Valle
Supervisory board
Dr. Dieter Schenk, Dr. Dorothea Wenzel, Gregory Sorensen, MD, Pascale Witz, Prof. Dr. Gregor Zünd, Rolf A. Classon
 

Company data

Name: Fresenius Medical Care AG & Co. KGaA
Address: Else-Kröner-Straße 1,D-61352 Bad Homburg
Phone: +49-6172-609-0
Fax: +49-6172-609-2301
E-mail: -
Internet: www.fmc-ag.de
Industry: Healthcare
Sector: Medical Products
Sub sector: Advanced Medical Devices
End of financial year: 12/31
Free Float: 44.95%
IPO date: 10/2/1996

Investor relations

Name: Dr. Dominic Heger
IR phone: +49-6172-609-2601
IR Fax: -
IR e-mail: ir@fmc-ag.com

Company calendar

CW 19 | 5/9/2023 Interim Report 1st Quarter/3 Months
CW 20 | 5/16/2023 General Shareholder Meeting
CW 31 | 8/2/2023 Interim Report 2nd Quarter/6 Months
CW 44 | 11/2/2023 Interim Report 3rd Quarter/9 Months
 

Main Shareholders

Freefloat
 
 44.95%
Fresenius SE & Co. KGaA
 
 32.00%
Thornburg Investment Management Inc.
 
 4.96%
BlackRock, Inc.
 
 3.16%
Richard Pzena
 
 3.01%
Artisan Partners Asset Management Inc.
 
 2.99%
Harris Associates L.P.
 
 2.98%
FIL Limited
 
 2.98%
Norges Bank
 
 2.97%